Dutch veterinarians order German autogenous vaccine against bluetongue

게시됨 2024년 4월 19일

Tridge 요약

In the Netherlands, there's a growing interest among veterinary practices to import a German autogenous vaccine aimed at combating bluetongue serotype 3, a virus traced back to North Rhine-Westphalia, Germany. Reinard Everts, director of the Dutch sheep and goat breeders' organization NSFO, highlighted this trend. However, the Dutch Ministry of Agriculture, Nature and Food Quality, along with the Royal Dutch Society for Veterinary Medicine, maintains strict regulations against the widespread use of such vaccines. Concerns revolve around safety, efficacy, and the risk of contamination, limiting the vaccine's application to specific company cases within the country.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

Reinard Everts, director of the Dutch sheep and goat breeders' organization NSFO, thinks that there are dozens of veterinary practices that have ordered the German autogenous vaccine or are considering doing so. The Royal Dutch Society for Veterinary Medicine has also received signals about this. The autogenous vaccine is an inactivated vaccine based on a virus isolate obtained from a company in North Rhine-Westphalia where bluetongue serotype 3 had been diagnosed. The use of the vaccine in Germany is only permitted in the states of North Rhine-Westphalia and Lower Saxony. The use of an autogenous vaccine in the Netherlands is only permitted for a company-specific approach to animal diseases and not for broad application. There are risks associated with the use ...
출처: Agri Holland

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.